Harry E. Carmitchel, Chief Operating Officer at OSIRIS THERAPEUTICS, INC. (OSIR), sold 5,000 shares at $20.35 ($102K) on 2008-12-03, disclosed to the SEC on 2008-12-05.
Open-market sale of $102k OSIR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.